Article: Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival

€3.03

SKU: product-article-43224 Category: General

Description
Reviews (0)

Description

Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival

Reviews

There are no reviews yet.

Be the first to review “Article: Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival”

You must be logged in to post a review.

Top

Article: Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in squamous cell carcinoma of the head and neck

Article: INTRODUCTION

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer